United Capital Management Of Ks, Inc. Bristol Myers Squibb CO Transaction History

United Capital Management Of Ks, Inc.

$420 Million
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$63.71 - $70.74 $46,317 - $51,427	727 Added 1.24%	59,574 $3.81 Million
Q1 2023 Apr 27, 2023	BUY	$65.71 - $74.53 $62,293 - $70,654	948 Added 1.64%	58,847 $4.08 Million
Q4 2022 Jan 31, 2023	SELL	$68.48 - $81.09 $122,099 - $144,583	-1,783 Reduced 2.99%	57,899 $4.17 Million
Q3 2022 Oct 31, 2022	BUY	$0.13 - $76.84 $5 - $3,073	40 Added 0.07%	59,682 $4.24 Million
Q2 2022 Aug 04, 2022	SELL	$72.62 - $79.98 $111,035 - $122,289	-1,529 Reduced 2.5%	59,642 $4.59 Million
Q1 2022 Apr 26, 2022	SELL	$61.48 - $73.72 $84,227 - $100,996	-1,370 Reduced 2.19%	61,171 $4.47 Million
Q4 2021 Jan 18, 2022	BUY	$53.63 - $62.52 $372,299 - $434,013	6,942 Added 12.49%	62,541 $3.9 Million
Q3 2021 Oct 27, 2021	BUY	$59.17 - $69.31 $276,501 - $323,885	4,673 Added 9.18%	55,599 $3.29 Million
Q2 2021 Jul 26, 2021	BUY	$61.91 - $67.42 $201,764 - $219,721	3,259 Added 6.84%	50,926 $3.4 Million
Q1 2021 Apr 27, 2021	BUY	$59.34 - $66.74 $144,136 - $162,111	2,429 Added 5.37%	47,667 $3.01 Million
Q4 2020 Jan 21, 2021	BUY	$57.74 - $65.43 $150,008 - $169,987	2,598 Added 6.09%	45,238 $2.81 Million
Q3 2020 Oct 19, 2020	BUY	$57.43 - $63.64 $261,823 - $290,134	4,559 Added 11.97%	42,640 $2.57 Million
Q2 2020 Jul 17, 2020	BUY	$54.82 - $64.09 $838,142 - $979,872	15,289 Added 67.08%	38,081 $2.24 Million
Q1 2020 May 04, 2020	BUY	$46.4 - $67.43 $204,438 - $297,096	4,406 Added 23.96%	22,792 $1.27 Million
Q4 2019 Jan 24, 2020	BUY	$49.21 - $64.19 $59,593 - $77,734	1,211 Added 7.05%	18,386 $1.18 Million
Q3 2019 Oct 15, 2019	BUY	$42.77 - $50.71 $101,151 - $119,929	2,365 Added 15.97%	17,175 $874,000
Q2 2019 Jul 25, 2019	BUY	$44.62 - $49.34 $56,890 - $62,908	1,275 Added 9.42%	14,810 $684,000
Q1 2019 May 01, 2019	BUY	$45.12 - $53.8 $155,032 - $184,856	3,436 Added 34.02%	13,535 $604,000
Q4 2018 Jan 10, 2019	BUY	$48.76 - $63.23 $79,186 - $102,685	1,624 Added 19.16%	10,099 $525,000
Q3 2018 Oct 09, 2018	BUY	$55.19 - $62.25 $467,735 - $527,568	8,475 New	8,475 $515,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Management Of Ks, Inc., based on Form 13F filings with the SEC.

News

Stay updated on United Capital Management Of Ks, Inc. with notifications on news.

Account